Celgene Corporation - CELG (NASDAQ-GS)

78.80
0.34 (-0.43%)
Quotes delayed 15 mins. Currently June 23, 2018 3:28:07 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Celgene develops and markets therapeutics to treat cancer and immune-inflammatory related diseases

Key Financials

Day Range:78.72 - 79.88
52 Week Range:74.13 - 147.17
Open:79.30
Shares:706.84M
Market Cap:55.70B
EPS:3.54
P/E Ratio:22.30
Div Yield:--
Performance
Previous close
No Chart Available
Purchase CELG in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of CELG not only as a single stock, but also as part of a motif.
Professional Motifs with CELG
Battling Cancer
Battling Cancer 22.5% 1 YR RTN New drugs and devices could be a game-changer for the war on the nation's second-biggest killer.
Biotech Breakthroughs
Biotech Breakthroughs 1.4% 1 YR RTN Biotech firms are breathing new life into hope for cures for complex diseases like cancer, arthritis and AIDS.
View all professional motifs with CELG
Community Motifs with CELG
Value for Money
Value for Money 26.2% 1 YR RTN
Spare change only
Spare change only 15.0% 1 YR RTN
View all community motifs with CELG
What Others Think About CELG
Bibey Post
Lucas Capital Management Has Boosted Celgene $CELG Holding by $311,062; As Verizon Communications $VZ Valuation Dec… twitter.com/i/web/status/1…
Bibey Post
Logitech Intl S A $LOGI Shareholder Suntrust Banks Cut Its Position by $442,656 as Market Value Rose; As Celgene… twitter.com/i/web/status/1…
Utah Herald
Argent Trust Company Decreased Its Centene $CNC Stake as Stock Value Rose; Celgene Cmn $CELG Shareholder Selkirk Ma… twitter.com/i/web/status/1…
1
Ani Anirudhan
RT @Benzinga : Evercore ISI Says Bluebird Bio Has Path To Commercialization, Madrigal Pharma Outpaced By Mid-Cap Alternatives https://t.co/J…
2
Trading News
RT @Benzinga : Evercore ISI Says Bluebird Bio Has Path To Commercialization, Madrigal Pharma Outpaced By Mid-Cap Alternatives https://t.co/J…
2
Benzinga.com
Evercore ISI Says Bluebird Bio Has Path To Commercialization, Madrigal Pharma Outpaced By Mid-Cap Alternatives… twitter.com/i/web/status/1…
2
The Norman Weekly
Celgene $CELG Holder Garrison Bradford & Associates Decreased Its Stake by $396,050; Cedar Rock Capital LTD Boosted… twitter.com/i/web/status/1…
News About CELG
Yahoo Finance (Fri, Jun 22)
Related Companies Within The Biotechnology Sector
Amgen Inc. - 185.15
AMGN
GILD
Biogen Inc. - 296.04
BIIB
SHPG
Shire plc - 161.85
SHPG
Illumina Inc. - 282.65
ILMN